136 related articles for article (PubMed ID: 30267305)
1. Exceptionally Selective Substrate Targeting by the Metalloprotease Anthrax Lethal Factor.
Turk BE
Adv Exp Med Biol; 2019; 1111():189-203. PubMed ID: 30267305
[TBL] [Abstract][Full Text] [Related]
2. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Substrate-selective Exosite within the Metalloproteinase Anthrax Lethal Factor.
Goldberg AB; Cho E; Miller CJ; Lou HJ; Turk BE
J Biol Chem; 2017 Jan; 292(3):814-825. PubMed ID: 27909054
[TBL] [Abstract][Full Text] [Related]
4. Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.
Bromberg-White J; Lee CS; Duesbery N
Toxins (Basel); 2010 May; 2(5):1038-53. PubMed ID: 22069624
[TBL] [Abstract][Full Text] [Related]
5. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
Tonello F; Montecucco C
Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
[TBL] [Abstract][Full Text] [Related]
6. Substrate recognition of anthrax lethal factor examined by combinatorial and pre-steady-state kinetic approaches.
Zakharova MY; Kuznetsov NA; Dubiley SA; Kozyr AV; Fedorova OS; Chudakov DM; Knorre DG; Shemyakin IG; Gabibov AG; Kolesnikov AV
J Biol Chem; 2009 Jul; 284(27):17902-13. PubMed ID: 19359249
[TBL] [Abstract][Full Text] [Related]
7. Anthrax lethal factor cleaves regulatory subunits of phosphoinositide-3 kinase to contribute to toxin lethality.
Mendenhall MA; Liu S; Portley MK; O'Mard D; Fattah R; Szabo R; Bugge TH; Khillan JS; Leppla SH; Moayeri M
Nat Microbiol; 2020 Dec; 5(12):1464-1471. PubMed ID: 32895527
[TBL] [Abstract][Full Text] [Related]
8. An enzymatic electrochemiluminescence assay for the lethal factor of anthrax.
Rivera VR; Merrill GA; White JA; Poli MA
Anal Biochem; 2003 Oct; 321(1):125-30. PubMed ID: 12963063
[TBL] [Abstract][Full Text] [Related]
9. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
[TBL] [Abstract][Full Text] [Related]
10. Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.
Kocer SS; Walker SG; Zerler B; Golub LM; Simon SR
Infect Immun; 2005 Nov; 73(11):7548-57. PubMed ID: 16239558
[TBL] [Abstract][Full Text] [Related]
11. Development of high-throughput assay of lethal factor using native substrate.
Kim J; Choi MK; Koo BS; Yoon MY
Anal Biochem; 2005 Jun; 341(1):33-9. PubMed ID: 15866525
[TBL] [Abstract][Full Text] [Related]
12. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
Xu L; Frucht DM
Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
[TBL] [Abstract][Full Text] [Related]
13. The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited.
Tonello F; Ascenzi P; Montecucco C
J Biol Chem; 2003 Oct; 278(41):40075-8. PubMed ID: 12888555
[TBL] [Abstract][Full Text] [Related]
14. Purification and biophysical characterization of the core protease domain of anthrax lethal factor.
Gkazonis PV; Dalkas GA; Chasapis CT; Vlamis-Gardikas A; Bentrop D; Spyroulias GA
Biochem Biophys Res Commun; 2010 Jun; 396(3):643-7. PubMed ID: 20438702
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
Duesbery NS; Webb CP; Leppla SH; Gordon VM; Klimpel KR; Copeland TD; Ahn NG; Oskarsson MK; Fukasawa K; Paull KD; Vande Woude GF
Science; 1998 May; 280(5364):734-7. PubMed ID: 9563949
[TBL] [Abstract][Full Text] [Related]
16. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
[TBL] [Abstract][Full Text] [Related]
17. Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.
Joshi M; Ebalunode JO; Briggs JM
Proteins; 2009 May; 75(2):323-35. PubMed ID: 18831046
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the anthrax lethal factor.
Pannifer AD; Wong TY; Schwarzenbacher R; Renatus M; Petosa C; Bienkowska J; Lacy DB; Collier RJ; Park S; Leppla SH; Hanna P; Liddington RC
Nature; 2001 Nov; 414(6860):229-33. PubMed ID: 11700563
[TBL] [Abstract][Full Text] [Related]
19. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
Vitale G; Pellizzari R; Recchi C; Napolitani G; Mock M; Montecucco C
Biochem Biophys Res Commun; 1998 Jul; 248(3):706-11. PubMed ID: 9703991
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
Lee LV; Bower KE; Liang FS; Shi J; Wu D; Sucheck SJ; Vogt PK; Wong CH
J Am Chem Soc; 2004 Apr; 126(15):4774-5. PubMed ID: 15080670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
